Cite
HARVARD Citation
Furie, R. et al. (2021). Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus. Lupus. pp. 1254-1263. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Furie, R. et al. (2021). Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus. Lupus. pp. 1254-1263. [Online].